« Return to News | Awards & Advancement

Dedicated Phase I Appoints New CMO

Friday, June 26, 2009 10:54 AM

Dedicated Phase I in Phoenix, Ariz., named a new chief medical officer to head its 80-bed phase I clinical research facility. Clark Springgate, M.D., Ph.D., brings more than 25 years' experience to the organization, having directed and participated in more than 256 clinical trials, including first-in-man and first-in-therapeutic-class studies.

"Having Dr. Springgate lead our clinical team furthers our commitment to bringing internationally known research physicians to Dedicated Phase I and Arizona's bioscience community," said Dedicated Phase I's founder and CEO Jason Bonanza.

In other recent personnel news from the clinical trial industry:

WuXi PharmaTech appointed Hao Zhou vice president of finance, responsible for financial planning and analysis, enterprise resource planning implementation, tax and treasury. Zhou worked for General Electric for 11 years before joining WuXi.

INC Research appointed Tom Zoda, Ph.D., as senior vice president of neuropsychiatry to the CRO's central nervous system team. Zoda will oversee all psychiatry and neurology projects on a global basis. Prior to joining INC, Zoda worked for PPD as executive director for Global Strategic Development, CNS.

West Coast Clinical Trials (WCCT) named Thomas Pillsworth, Ph.D., the new vice president of business development. Prior to joining WCCT, Pillsworth was vice president of business development at PharmaNet working in both the early- and late-stage divisions.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

December 17

Medici Global says its Alzheimer's Facebook page demonstrates the need for more early detection trials

Analysts: Expect more equity purchases of CROs in 2013

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

January 2013

Parexel celebrates 30 years of change, growth
CRO's founder and chairman reflects on challenges of the past, present and future

Strategies for increasing patient diversity in trials
Sponsors look to improve racial, ethnic recruitment without going overseas

Already a subscriber?
Log in to your digital subscription.

Purchase the January issue.

Subscribe to The CenterWatch Monthly.

December 2012

Publicity, regulation tightening reins on use of KOLs
Debate rages over need to revamp how sponsors use, pay medical experts

Time may be right to makeover the investigator brochure
Size, complexity prevent critical document from being thoroughly read

Already a subscriber?
Log in to your digital subscription.

Purchase the December issue.

Subscribe to The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.